FDA Clearance Tracker · K251325
VersaCross Connect Transseptal Dilator
Last checked: Nov 20, 2026Latest source record: May 29, 2025 (this decision)Source: openFDAMethods & limitations
Decided
May 29, 2025
Substantially Equivalent
Time to decision
30 days
Received Apr 29, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K251325
- Device name
- VersaCross Connect Transseptal Dilator
- Applicant
- Baylis Medical Company, Inc.
- Applicant location
- Mississauga, CA
- Received
- Apr 29, 2025
- Decided
- May 29, 2025
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.1310
- Specialty
- CardiologyInterventional Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code DRE. The earliest in FDA's data is K760403, decided Aug 23, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K251325
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Baylis Medical Company, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K241720 · Decided Jul 12, 2024 · 28 days after receipt
Device type: Dilator, Vessel, For Percutaneous Catheterization (DRE) · Cardiology
K231227 · Decided Dec 20, 2023 · 236 days after receipt
Device type: Introducer, Catheter (DYB) · Cardiology
K233647 · Decided Dec 14, 2023 · 30 days after receipt
Device type: Dilator, Vessel, For Percutaneous Catheterization (DRE) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.